Clinical trials
Adolescent clinical trials
Below are recruiting adolescent clinical trials, each written for real people, not researchers. We’re tracking 955 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07650916RecruitingPhase 3
A study of two ultra-long-acting HIV shots
This trial tests a new ultra-long-acting injectable combination of cabotegravir and rilpivirine for people with HIV who already have the virus under control. It aims to see if these shots can keep the virus suppressed with fewer doses.
Phoenix, ArizonaAges 12 years+ - NCT07754149Recruiting
Progressive resistance training for PMS in teen girls
This study tests whether a 6-week progressive strength training program can reduce symptoms of premenstrual syndrome (PMS) in teenage girls. It compares different exercise intensities to see what works best and may offer a drug-free way to manage PMS.
Islamabad, FederalAges 11–19 - NCT07196241Recruiting
Care needs survey for young adults with cancer
This is a survey study to understand the needs of young adults (ages 15-39 at diagnosis) who have had cancer treatment. Your answers will help improve care for others like you.
Charlotte, North CarolinaAges 15 years+ - NCT07348666Recruiting
Smartphone safety planning for teens at risk
This trial tests a smartphone-based safety planning tool that gives you support right when you need it. It's designed for teens and young adults who are at risk for suicide and are already getting care at participating clinics.
Eugene, OregonAges 13–24 - NCT07575308RecruitingPhase 2
ALN-6400 for Heavy Bleeding in von Willebrand Disease
This trial tests a new medicine called ALN-6400 in teenage and adult women with von Willebrand disease (a blood clotting condition) who experience heavy menstrual bleeding. The goal is to see if this treatment can reduce bleeding and improve quality of life.
Los Angeles, CaliforniaAges 16–45 - NCT06131983RecruitingPhase 1/Phase 2
Study drug for facioscapulohumeral muscular dystrophy type 1
This trial is testing an investigational drug, SRP-1001, to see if it helps people with facioscapulohumeral muscular dystrophy type 1 (FSHD1), a condition that causes muscle weakness. The study will check if the drug is safe and if it can slow down the loss of muscle function.
Liverpool, New South WalesAges 16–70 - NCT04963751Recruiting
Pre-surgery counseling for teens having abdominal surgery
This trial offers counseling before surgery for children and teens to help them prepare and understand what to expect. It is designed for people having abdominal surgery under an ERAS pathway, which is a structured plan to support safer, smoother recovery.
Aurora, ColoradoAges 9–17 - NCT07221851RecruitingPhase 3
Weekly vs daily growth hormone for short stature in children
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
Palo Alto, CaliforniaAges 2–17 - NCT06386198Recruiting
Health Advocate for Young Liver Transplant Patients
This study tests a program that helps young adults with a liver transplant prepare to move from a children’s hospital to an adult hospital. It aims to provide extra support for people who also have social needs like trouble getting enough food.
San Francisco, CaliforniaAges 18–25 - NCT06979453RecruitingPhase 3
A study of deucravacitinib for teens with plaque psoriasis
This trial tests an investigational oral medication called deucravacitinib for teenagers (adolescents) with moderate to severe plaque psoriasis. It aims to see if the drug is safe and works well.
Birmingham, AlabamaAges 12–17 - NCT06351501RecruitingPhase 3
Hormone treatment for gender dysphoria in teenagers
This study tests whether hormone therapy (such as testosterone or estrogen) helps reduce distress in teenagers who feel their gender does not match their body. It aims to see if starting hormones at this age improves mental well-being and overall quality of life.
ParisAges 13–14 - NCT05664737RecruitingPhase 2
Luspatercept for adults with alpha thalassemia
This study tests a medicine called luspatercept to see if it can help people with alpha thalassemia need fewer blood transfusions. It is for adults and some teens with this condition.
Halifax, Nova ScotiaAges 12 years+ - NCT06745557RecruitingPhase 3
Testing a new lab-grown skin patch for large burns
This trial tests a new skin patch made from your own cells to treat large, deep burns. It’s for people who need skin grafts and may help reduce scarring and improve healing.
LiègeAges 12 years+ - NCT07058077RecruitingPhase 2/Phase 3
Study of oral cholesterol-lowering pill in children with HeFH
This study tests an experimental daily pill (enlicitide decanoate) that lowers LDL ('bad') cholesterol in children and teens with a genetic condition called heterozygous familial hypercholesterolemia (HeFH). It aims to see if this medicine can safely help reduce their high cholesterol levels.
Wilmington, DelawareAges 6–17 - NCT06670066Recruiting
Trial of let's talk birth control
This trial tests a program to help teens and young adults learn about birth control options during regular health visits. It may help you find the right method for your needs.
Sioux City, IowaAges 15–24 - NCT05999994RecruitingPhase 2
Testing new drugs for children and young adults with cancer
This trial tests several experimental drugs for children and young adults with cancer. It aims to find safe and effective treatments by matching participants to one of several drug studies based on their cancer type and health.
Birmingham, AlabamaAges 1–39 - NCT06900595RecruitingPhase 2
Cabozantinib with immunotherapy for advanced adrenal cancer
This trial tests adding the targeted drug cabozantinib to the immunotherapy cemiplimab for people with advanced adrenocortical carcinoma that cannot be removed by surgery or has spread. It checks if the combination works better than cabozantinib alone.
La Jolla, CaliforniaAges 12 years+ - NCT07080905RecruitingPhase 3
Gene therapy for teens with severe hemophilia B
This trial tests a single dose of CSL222, a gene therapy, in adolescent boys with severe or moderately severe hemophilia B. The goal is to see if it can reduce or eliminate the need for regular factor IX infusions.
Orange, CaliforniaAges 11.5 years–17.2 years - NCT06309134Recruiting
Healthy families program for LGBTQ+ teens
This study tests a program for teens and their caregivers to support healthy relationships. It is designed for sexual or gender minority teens aged 15-18 who have had a dating or sexual relationship recently.
Colorado Springs, ColoradoAges 15–18 - NCT05887973Recruiting
Youth gun violence prevention program in Washington, DC
This trial is focused on preventing firearm violence by addressing underlying causes among youth taking part in a specific DC grassroots program. If you’re a youth involved with that program in Washington, DC, this study may fit you.
Ann Arbor, MichiganAges 14–24 - NCT05722535Recruiting
Help families plan healthy media use together
This trial helps parents and their teens make a shared plan for how the family uses screens and media. It tests whether a shared decision-making approach can improve planning at home.
Seattle, WashingtonAges 11 years+ - NCT05338944Recruiting
Dialectal behavior therapy for teens with obesity and low mood
This study tests whether Dialectal Behavior Therapy (DBT)—a structured skills-based counseling program—can help teens make healthier behavior changes. It is for teens who have obesity and mild to moderate symptoms of depression, and it checks whether they can follow the study plan.
Calgary, AlbertaAges 14–17 - NCT04067596Recruiting
Growth-limiting leg surgery for very tall teens
This trial looks at a surgery that slows future height growth in adolescents who are very tall and still growing. It may help reduce how much more height they may gain by limiting growth at the knee/leg growth plates.
CréteilAges 8 years+ - NCT07750795Recruiting
Nutrition and activity lessons for kids with celiac disease
This study teaches kids with celiac disease about healthy eating and physical activity to help them manage their condition better. It aims to improve their daily habits and overall well-being.
Istanbul, BesiktasAges 8–12
Hear when a new Adolescent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adolescent?
- Yes. Clin2 currently lists 955 recruiting adolescent studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adolescent trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adolescent trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.